A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China

Summary

The primary objective of this study is to evaluate whether, after two 8-week treatment periods, male patients with erectile dysfunction (ED) in China prefer 20 milligram (mg) tadalafil or 100 mg sildenafil. This trial consists of two treatment periods of 8 weeks each and an extension phase of 8 weeks, for a total of 24 weeks.

Timeline

Start

2011-06

Primary completion

2012-06

Completion

2012-07

Outcome

Met primary endpoint

registry NUMBER All Randomized Participants: 69.1 (64 to 74) percentage of participants NCT01352507 ↗

registry analysis (superiority or other test); All Randomized Participants; p <0.001; Wilson Score method NCT01352507 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	100 mg	Oral
Subject	Tadalafil	Small molecule	20 mg	Oral

Indications